U.S. Specialty Stores Stock News

NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

3 Top Dividend Stocks Yielding Up To 4.7%

The United States market has shown impressive growth, rising 4.2% over the last week and 29% over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying strong dividend stocks that offer both stability and attractive yields can be a key strategy for investors seeking consistent income alongside potential capital appreciation.
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

US Stock Market Today S&P 500 Futures Edge Higher As Rate Worries Ease

The Morning Bull - US Market Morning Update Tuesday, Apr, 14 2026 E-mini S&P 500 futures are pointing slightly higher this morning, with a gain of about 0.2% as investors weigh softer inflation signals against signs of strain in housing. The US 10 year Treasury yield is around 4.29%, which suggests some easing of interest rate fears as Iran peace talk hopes cool expectations of future price spikes. At the same time, March existing home sales are at a 9 month low of 3.98 million annualized,...
NYSE:MS
NYSE:MSCapital Markets

Is It Too Late To Consider Morgan Stanley (MS) After A 70% One-Year Rally?

If you are wondering whether Morgan Stanley at around US$181 per share still offers value or is starting to look stretched, the key is to separate price excitement from underlying worth. The stock's recent returns, including 8.8% over 7 days, 17.0% over 30 days and 70.5% over 1 year, along with a relatively flat year to date move of a 0.4% decline, suggest the market has been reassessing the story over different time frames. Recent coverage has focused on Morgan Stanley as a major global...
NYSE:JEF
NYSE:JEFCapital Markets

Is It Too Late To Consider Jefferies Financial Group (JEF) After Its Recent Share Price Rebound

Wondering if Jefferies Financial Group, at around US$46 per share, still offers value or if most of the opportunity is already reflected in the price. The stock has moved sharply in the short term, with a 10.1% return over 7 days and 27.1% over 30 days, set against a year-to-date return of a 27.2% decline and a 1-year return of 8.7% that sits within a longer 3-year return of 60.7% and 5-year return of 71.7%. These moves sit alongside ongoing interest in capital markets and corporate...
NasdaqGS:ODFL
NasdaqGS:ODFLTransportation

Old Dominion Freight Line (ODFL) Valuation Check As Profits And Returns Weaken

Why Old Dominion Freight Line Is Back in Focus Old Dominion Freight Line (ODFL) is back on investors' radar after two years of annual sales declines of 3.2% and earnings per share falling 7.2%, which has raised fresh questions about its profitability trend. See our latest analysis for Old Dominion Freight Line. Despite the weakening earnings trend, momentum in the share price has been strong recently, with a 30.43% year to date share price return and a 34.80% total shareholder return over the...
NYSE:PNW
NYSE:PNWElectric Utilities

A Look At Pinnacle West Capital (PNW) Valuation As Shares Hit A New 52-Week High

Pinnacle West Capital (PNW) recently hit a new 52 week high after expanding its unsecured revolving credit facility to US$300,000,000. This has drawn attention to how the company is funding growth in response to rising electricity demand in Phoenix. See our latest analysis for Pinnacle West Capital. The new 52 week high sits alongside a 16.44% year to date share price return and a 13.94% total shareholder return over the past year, with momentum building over the last 90 days as the stock...
NYSE:CSW
NYSE:CSWBuilding

Does CSW Industrials’ (CSW) Dividend Hike and Incentive Plan Reveal a Deeper Capital Allocation Shift?

CSW Industrials, Inc. recently declared a regular quarterly cash dividend of US$0.30 per share, an increase of US$0.03 per share, or about 11%, payable on May 8, 2026 to shareholders of record on April 24, 2026, and granted 211 performance rights to Vice President and Chief Accounting Officer Fang Wang tied to relative total shareholder return. Together, the dividend increase and performance-based equity award underscore management’s confidence in the business while aligning executive...
NYSE:BSM
NYSE:BSMOil and Gas

A Look At Black Stone Minerals (BSM) Valuation After Recent Share Price Pressure

Black Stone Minerals (BSM) has drawn fresh attention after recent share price pressure, with the stock showing a negative return over the past month while remaining positive on a year to date basis. See our latest analysis for Black Stone Minerals. With the share price at US$13.90, recent pressure is clear, including a 9.68% 1 month share price decline. However, the 1 year total shareholder return of 9.27% and 5 year total shareholder return of 126.63% point to a much stronger long term...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk’s Thalassemia Push Adds Rare Blood Upside To Valuation

Novo Nordisk (NYSE:NVO) is progressing etavopivat, a therapy candidate for thalassemia, in its rare blood disorders pipeline. The company is pairing this clinical work with regulatory activities in key markets, signaling a push into hematology. This move comes as most recent investor focus has centered on obesity care and Alzheimer’s disease programs. Novo Nordisk is widely associated with obesity and diabetes treatments, and more recently with interest around Alzheimer’s disease research...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Fastenal (FAST) Earnings Growth And 15.3% Margin Test Rich Valuation Narrative

Fastenal (FAST) just posted its Q1 2026 scorecard, with recent quarterly numbers showing Q4 2025 revenue of about US$2.0b and basic EPS of US$0.26, alongside trailing twelve month basic EPS of US$1.10 on revenue of roughly US$8.2b. The company has seen revenue move from US$1.82b in Q4 2024 to about US$2.03b in Q4 2025, while quarterly basic EPS shifted from US$0.23 to US$0.26 over the same period, setting up this latest report against a backdrop of steady top line and per share earnings. With...
NYSE:MO
NYSE:MOTobacco

Altria’s On Plus Launch Tests FDA Program And Smoke Free Strategy

Altria Group (NYSE:MO) is rolling out its on! PLUS nicotine pouches nationally across the U.S. on! PLUS is the first product cleared under the FDA's pilot accelerated review program for tobacco products. The launch comes as competition in the U.S. nicotine market intensifies and regulatory oversight stays active. Altria is best known for its U.S. cigarette and oral tobacco businesses, and the on! PLUS launch signals a stronger push into smoke free nicotine products. The FDA's pilot...
NYSE:UBER
NYSE:UBERTransportation

A Look At Uber Technologies (UBER) Valuation After Strong Cash Flow And Autonomous Expansion News

Uber Technologies (UBER) is drawing fresh attention after reporting strong Q4 2025 operating trends, including 22% trip growth, record free cash flow of US$2.81b, and guidance for 37% non GAAP EPS growth in Q1 2026. See our latest analysis for Uber Technologies. At a share price of US$72.34, the stock has a 1 day share price return of 2.64% but a 90 day share price return showing a decline of 15.30%, while the 3 year total shareholder return of 125.50% points to strong longer term...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum

Why Catalyst Pharmaceuticals Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn fresh attention after recent trading, with the share price closing at $25.34. Investors are weighing this level against the company’s current earnings profile and rare disease focus. See our latest analysis for Catalyst Pharmaceuticals. The 1-day share price return of 1.6% builds on a 30-day share price return of 9.1% and a three year total shareholder return of 40.2%, pointing to momentum that has...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen And Zai Lab DLL3 Alliance Adds New Dimension To Oncology Story

Amgen (NasdaqGS:AMGN) and Zai Lab have agreed to a global clinical trial collaboration focused on small cell lung cancer. The partnership will evaluate a combination of two DLL3 targeting therapies, Amgen's IMDELLTRA and Zai Lab’s zocilurtatug pelitecan. This is described as a first of its kind combination of a BiTE therapy and an antibody drug conjugate in this setting. Amgen, trading at $349.82, has seen its share price move 2.1% over the past week and 6.8% year to date, with a 22.8%...
NYSE:BXMT
NYSE:BXMTMortgage REITs

A Look At Blackstone Mortgage Trust (BXMT) Valuation After Recent Share Price Momentum

What recent returns signal for Blackstone Mortgage Trust Blackstone Mortgage Trust (BXMT) has drawn investor attention after a series of recent returns, including a 0.9% move over the past day and gains across the past week, month, and past 3 months. See our latest analysis for Blackstone Mortgage Trust. At a share price of $19.78, Blackstone Mortgage Trust has paired a 6.9% 7 day share price return with a 20.6% 1 year total shareholder return, suggesting recent momentum has added to longer...
NYSE:AOS
NYSE:AOSBuilding

A Look At A. O. Smith (AOS) Valuation After Recent Share Price Momentum

A. O. Smith (AOS) has attracted attention after recent share price moves, with the stock up about 1.9% over the past day and 3.9% over the past week, prompting closer scrutiny from investors. See our latest analysis for A. O. Smith. While the recent 1-day and 7-day share price returns suggest short-term momentum, the 90-day share price return of 4.8% and modest multi year total shareholder returns indicate a more muted longer term picture. If this kind of steady industrial name is on your...
NYSE:MLM
NYSE:MLMBasic Materials

Congress Member Purchase Highlights Valuation And Momentum At Martin Marietta Materials

Representative April McClain Delaney recently bought shares of Martin Marietta Materials (NYSE:MLM). The transaction involves a sitting member of Congress, drawing attention to the company and its current valuation. The purchase comes as Martin Marietta Materials trades around $635.29 per share. Martin Marietta Materials, trading on the NYSE under the ticker MLM, sits at a share price of about $635.29. The stock has returned 6.2% over the past week, 8.8% over the past month, and 27.0% over...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Produce Earnings Strength Questioned By Stagnant Sales And Margins

Fresh Del Monte Produce (NYSE:FDP) recently reported strong quarterly earnings, highlighting solid profitability in the most recent period. At the same time, the company continues to face long running revenue stagnation, a weaker revenue outlook, and structural profitability pressures. These mixed signals are raising questions about how sustainable the latest results may be without deeper business changes. Fresh Del Monte Produce, a global supplier of fresh and fresh cut fruits and...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

A Look At Palomar Holdings (PLMR) Valuation After Keefe Bruyette Woods Price Target Hike And Outperform Reaffirmation

Palomar Holdings (PLMR) is back on traders’ screens after a price target hike and reaffirmed Outperform rating from Keefe, Bruyette & Woods, a move that coincides with generally positive analyst sentiment. See our latest analysis for Palomar Holdings. Recent trading reflects that renewed optimism, with a 5.35% 7 day share price return and a 6.81% 30 day share price return, set against a year to date share price decline of 2.61% and a three year total shareholder return of 139.07%. This...
NYSE:FND
NYSE:FNDSpecialty Retail

A Look At Floor & Decor (FND) Valuation After New Portland Store Opening And Recent Share Price Weakness

Floor & Decor Holdings (FND) is drawing investor attention after opening a new warehouse store and design center in the Portland metro area, extending its footprint beyond 270 warehouse-format locations nationwide. See our latest analysis for Floor & Decor Holdings. While the new Portland warehouse highlights ongoing expansion, the share price tells a different story, with a 30 day share price return of an 11.93% decline and a 1 year total shareholder return of a 31.27% decline. This suggests...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions (PENG) Is Up 20.3% After Raising 2026 Outlook Despite Revenue Decline – Has The Bull Case Changed?

In early April 2026, Penguin Solutions, Inc. reported second-quarter results showing lower revenue of US$343 million year on year but sharply higher net income of US$37.45 million and raised its full-year 2026 outlook to target 12% year over year net sales growth (plus or minus 5%) and diluted EPS of US$1.30 (plus or minus US$0.15). The company also filed employee stock ownership plan-related shelf registrations and saw several pre-planned insider stock sales, developments that contrast with...